Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 47,977 | 103,781 | 53,509 | 18,256 | 9,330 |
| Gross Profit | 47,977 | 103,781 | 53,509 | 18,256 | 9,330 |
| Operating Expenses | 121,338 | 82,300 | 95,706 | 106,227 | 88,443 |
| Operating Income | -73,361 | 21,481 | -42,197 | -87,971 | -79,113 |
| Interest Expense | 0 | 0 | 2,605 | 1,940 | 0 |
| Other Income | 4,795 | 3,923 | -1,613 | 155 | 833 |
| Pre-tax Income | -68,566 | 25,404 | -46,415 | -89,756 | -78,280 |
| Income Tax | N/A | 2,598 | N/A | N/A | N/A |
| Net Income Continuous | -68,566 | 22,806 | -46,415 | -89,756 | -78,280 |
| Net Income | $-68,566 | $22,806 | $-46,415 | $-89,756 | $-78,280 |
| EPS Basic Total Ops | -1.27 | 0.43 | -1.23 | -2.91 | -3.52 |
| EPS Basic Continuous Ops | -1.27 | 0.43 | -1.23 | -2.91 | -3.50 |
| EPS Diluted Total Ops | -1.27 | 0.43 | -1.23 | -2.91 | -3.52 |
| EPS Diluted Continuous Ops | -1.27 | 0.43 | -1.23 | -2.91 | -3.50 |
| EPS Diluted Before Non-Recurring Items | -1.27 | 0.51 | -1.23 | -2.91 | -3.52 |
| EBITDA(a) | $-73,359 | $21,848 | $-41,328 | $-87,325 | $-78,352 |